Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950144-03-013938
Filing Date
2003-12-23
Accepted
2003-12-23 11:50:38
Documents
5
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 ADVANCED VIRAL RESEARCH FORM 10-K/A#2 12/31/02 g86477e10vkza.txt 10-K/A 373987
3 CERTIFICATION OF CEO PURSUANT SECTION 302 g86477exv31w1.txt EX-31.1 4579
4 CERTIFICATIN OF CFO PURSUANT SECTION 302 g86477exv31w2.txt EX-31.2 4625
5 EX-32.1 CEO CERTIFICATION PURSUANT TO SECTION 906 g86477exv32w1.txt EX-32.1 1008
6 EX-32.2 CFO CERTIFICATION PURSUANT TO SECTION 906 g86477exv32w2.txt EX-32.2 1019
  Complete submission text file 0000950144-03-013938.txt   387385
Mailing Address 200 CORPORATE BOULEVARD SOUTH . YONKERS NY 10107
Business Address 200 CORPORATE BOULEVARD SOUTH . YONKERS NY 10107 9143767383
ADVANCED VIRAL RESEARCH CORP (Filer) CIK: 0000786623 (see all company filings)

EIN.: 592646820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 033-02262-A | Film No.: 031069938
SIC: 2834 Pharmaceutical Preparations